17 posts
Early screening is key, according to a Alzheimer's Association public health expert. The blood biomarker screening for Alzheimer's may have benefits, so speak with your doctor if the test is the right option for you.
A blood biomarker test for Alzheimer’s disease was approved by the Food and Drug Administration well over a year ago, in May 2025, but according to medical professionals and advocacy organizations like the Alzheimer’s Association, there is still a significant public knowledge gap.
Originally from Brooklyn, Barbara Weiss, 70, lives on Long Island, N.Y., with Dennis, 73, her husband of nearly 50 years, who received a diagnosis of mild cognitive impairment in 2023 and early-stage Alzheimer’s disease in 2026.
Alex Miller, 40, temporarily relocated to Alabama, where he was a primary caregiver for his father who was aging in place with dementia, glaucoma and other health issues. Today, Miller talks with his father every week, but wishes he could do more.
My dad Elliot Miller was ripped off. Desperate to provide for his family as a poor artist, he sold a painting called Father’s Love—and all of its rights—to a corporation that went on to make millions in reprints.
Kelly Glover is a co-caregiver with other relatives for her father who is aging in place with Alzheimer’s disease in N.J. Glover is a Congressional Team ACT Member, part of the Alzheimer’s Impact Movement (AIM), the sister organization of the Alzheimer’s Association.
Health Nation asked Dr. Manisha Santosh Parulekar, M.D., questions about the Alzheimer’s biomarker screening test. Here's what to know.
During an initial screening or diagnostic appointment, it's okay to have questions. Here are some common terms that you have may have heard before, but it can't hurt to have expert Dr. Manisha Santosh Parulekar review the basics.
